Abstract
Efficacious, effective and efficient communication between healthcare professionals (HCP) and patients is essential to achieve a successful therapeutic alliance. Telemedicine (TM) has been used for decades but during the COVID-19 pandemic its use has become widespread. This position paper aims to describe the terminology and most important forms of TM among HCP and patients and review the existing studies on the uses of TM for asthma and allergy. Besides, the advantages and risks of TM are discussed, concluding that TM application reduces costs and time for both, HCP and patients, but cannot completely replace face-to-face visits for physical examinations and certain tests that are critical in asthma and allergy. From an ethical point of view, it is important to identify those involved in the TM process, ensure confidentiality and use communication channels that fully guarantee the security of the information. Unmet needs and directions for the future regarding implementation, data protection, privacy regulations, methodology and efficacy are described.
| Original language | English |
|---|---|
| Journal | Allergy: European Journal of Allergy and Clinical Immunology |
| Early online date | 1 Dec 2023 |
| DOIs | |
| Publication status | E-pub ahead of print - 1 Dec 2023 |
Funding
The Telemedicine task force group within the Research and Outreach Committee (ROC) was supported by the European Academy of Allergy and Clinical Immunology (EAACI).
| Funders |
|---|
| European Academy of Allergy and Clinical Immunology |
Keywords
- e-health
- m-health
- telecare
- telehealth
- telemedicine
Fingerprint
Dive into the research topics of 'Telemedicine with special focus on allergic diseases and asthma—Status 2022: An EAACI position paper'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver